Evidence map›Paper›PMID 34535199›Full record

ArticleZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics

Shaanxi Provincial Diagnosis and Treatment Center of Kawasaki Disease.

Shaanxi Provincial Diagnosis and Treatment Center of Kawasaki Disease, Clinical Research Center for Childhood Diseases of Shaanxi Province, Children's Hospital of Shaanxi Provincial People's Hospital, Editorial Board of Chinese Journal of Contemporary Pediatrics, Expert Committee of Advanced Training for Pediatrician, China Maternal andChildren's Health Association, General Pediatrician Group, Society of Pediatrician, Chinese Doctor Association(Du ZD,Email: duzhongdong@126.com)

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. [DeepSeek perspective on managing Kawasaki disease in Chinese children].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025
    Article
  3. [Development of a predictive scoring model for non-response to intravenous immunoglobulin in Kawasaki disease].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025
    Article
  4. Article
  5. Article
  6. [Evidence-based guidelines for the diagnosis and treatment of Kawasaki disease in children in China (2023)].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2023
    Article
  7. [Diagnosis and treatment of incomplete Kawasaki disease in children].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2023
    Review
  8. Pediatric expert consensus on the application of glucocorticoids in Kawasaki disease.Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shaanxi Provincial Diagnosis and Treatment Center of Kawasaki Disease
Clinical Research Center for Childhood Diseases of Shaanxi Province
Children's Hospital of Shaanxi Provincial People's Hospital
Editorial Board of Chinese Journal of Contemporary Pediatrics
Expert Committee of Advanced Training for Pediatrician, China Maternal andChildren's Health Association
General Pediatrician Group, Society of Pediatrician, Chinese Doctor Association(Du ZD,Email: duzhongdong@126.com)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kawasaki disease is an acute, self-limited vascuitis that mainly occurs in children under 5 years of age. Intravenous immunoglobulin (IVIG) has become an effective treatment regimen, which can effectively reduce the incidence of cardiovascular complications. However, there has been no consensus or clinical guidelines for the application of IVIG in children with Kawasaki disease till now. This consensus is developed based on the current research progress on the application of IVIG in children with Kawasaki disease in China and overseas, with reference to the diagnosis and treatment guidelines for Kawasaki disease in China and overseas, and the opinions of experts. This consensus provides recommendations on the clinical application strategy of IVIG in children with Kawasaki disease and the prevention and treatment of its adverse reactions.

Indexed as

Heart DiseasesMucocutaneous Lymph Node SyndromeChildChild, PreschoolChinaHumansImmunoglobulins, IntravenousTreatment OutcomeImmunoglobulins, IntravenousChildExpert consensusIntravenous immunoglobulinKawasaki diseaseSelf-limited vasculitis

Identifiers

PMID34535199
PMCPMC8480171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.